Weight stigma intervention for Obesity

N/A
Recruiting
Led By A. Janet Tomiyama, Ph.D.
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
BMI greater than or equal to 28
BMI greater than or equal to 28
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upchange in sleep efficiency will be assessed by measuring sleep efficiency for three days before the intervention as part of the baseline, and three days after the intervention.
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will test whether weight stigma leads to worse health behaviors like sleep, diet, and physical activity.

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You have a body mass index (BMI) of 28 or higher.
Select...
Your body mass index (BMI) is 28 or higher.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in sleep onset latency will be assessed by measuring sleep onset latency for three days before the intervention as part of the baseline, and three days after the intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in sleep onset latency will be assessed by measuring sleep onset latency for three days before the intervention as part of the baseline, and three days after the intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in physical activity
Change in self-reported dietary intake
Change in self-reported sleep quality
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental (Weight Stigma) ArmExperimental Treatment1 Intervention
Participants undergoing the experimental (Weight Stigma) arm are exposed to an interaction partner (a trained confederate) who endorses anti-fat attitudes. Prior to their interaction, participants exchange a "Getting to Know You Questionnaire" with the confederate, where the confederate endorses anti-fat attitudes. During their interaction with the confederate, participants are told they will be completing consumer rating tasks with another participant in the study. During the ostensible consumer rating task, participants in the experimental condition rate items such as a diet magazine, body sunscreen, running shoes, and a size small T-shirt labeled as size large to bolster the weight stigma manipulation.
Group II: Control ArmActive Control1 Intervention
Participants undergoing the control arm are also exposed to an interaction partner (a trained confederate) who does not endorse anti-fat attitudes. Prior to their interaction, participants exchange a "Getting to Know You Questionnaire" with the confederate; however, the confederate does not endorse anti-fat attitudes. During their interaction with the confederate, participants are told they will be completing consumer rating tasks with another participant in the study. During the ostensible consumer rating task, participants in the control condition rate items such as an interior design magazine, face sunscreen, regular (non-running) shoes, and a size large T-shirt correctly labeled as size large to avoid weight stigma.

Find a site

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,474 Previous Clinical Trials
10,150,230 Total Patients Enrolled
26 Trials studying Obesity
24,873 Patients Enrolled for Obesity
University of California, San FranciscoOTHER
2,407 Previous Clinical Trials
12,272,444 Total Patients Enrolled
32 Trials studying Obesity
10,668 Patients Enrolled for Obesity
Miami UniversityOTHER
13 Previous Clinical Trials
2,540 Total Patients Enrolled
A. Janet Tomiyama, Ph.D.Principal Investigator
University of California, Los Angeles
2 Previous Clinical Trials
471 Total Patients Enrolled

Media Library

Weight stigma intervention Clinical Trial Eligibility Overview. Trial Name: NCT05402137 — N/A
Obesity Research Study Groups: Experimental (Weight Stigma) Arm, Control Arm
Obesity Clinical Trial 2023: Weight stigma intervention Highlights & Side Effects. Trial Name: NCT05402137 — N/A
Weight stigma intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05402137 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate amount of individuals participating in this experiment?

"Confirmed. The clinicaltrials.gov portal states that this research endeavor, posted on April 28th 2022 and most recently updated May 27th 2022, is actively searching for 330 participants from 1 site."

Answered by AI

Is there still capacity for additional participants in this research endeavor?

"Affirmative. Data from clinicaltrials.gov indicates that this trial is presently trying to recruit patients, beginning with the first post on April 28th 2022 and a most recent update occurring May 27th of the same year. This study requires 330 people from one site in particular for participation."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
University of California, Los Angeles
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. University of California, Los Angeles: < 48 hours
Average response time
  • < 2 Days
~114 spots leftby Jun 2024